Michael H. Kroll

3.7k total citations
90 papers, 2.8k citations indexed

About

Michael H. Kroll is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael H. Kroll has authored 90 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 24 papers in Internal Medicine and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael H. Kroll's work include Platelet Disorders and Treatments (31 papers), Venous Thromboembolism Diagnosis and Management (24 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Michael H. Kroll is often cited by papers focused on Platelet Disorders and Treatments (31 papers), Venous Thromboembolism Diagnosis and Management (24 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Michael H. Kroll collaborates with scholars based in United States, Finland and Belgium. Michael H. Kroll's co-authors include Andrew I. Schafer, William Durante, Shuju Feng, Julio C. Reséndiz, A I Schafer, Vahid Afshar‐Kharghan, Joel L. Moake, Kelly J. Peyton, T. Harris and RI Handin and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Michael H. Kroll

85 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael H. Kroll United States 29 997 867 433 428 366 90 2.8k
Junji Nishioka Japan 31 1.7k 1.7× 533 0.6× 345 0.8× 405 0.9× 515 1.4× 99 3.0k
Claudia Maria Radu Italy 29 779 0.8× 856 1.0× 235 0.5× 292 0.7× 188 0.5× 78 2.4k
Clifford M. Takemoto United States 27 726 0.7× 1.2k 1.4× 770 1.8× 239 0.6× 238 0.7× 78 3.3k
Mercè Roqué Spain 26 705 0.7× 826 1.0× 395 0.9× 880 2.1× 265 0.7× 72 2.9k
Kellie R. Machlus United States 26 1.7k 1.7× 673 0.8× 473 1.1× 370 0.9× 379 1.0× 70 3.0k
Dolors Tàssies Spain 30 842 0.8× 256 0.3× 578 1.3× 361 0.8× 284 0.8× 117 3.0k
Hatem H. Salem Australia 19 1.0k 1.0× 454 0.5× 240 0.6× 408 1.0× 168 0.5× 22 1.9k
Valerie P. Castle United States 32 843 0.8× 1.9k 2.2× 358 0.8× 206 0.5× 240 0.7× 75 4.2k
Jaroslav Čermák Czechia 25 2.1k 2.1× 1.5k 1.7× 385 0.9× 228 0.5× 788 2.2× 192 3.7k
Norma Maugeri Italy 31 584 0.6× 852 1.0× 1.5k 3.4× 275 0.6× 192 0.5× 67 2.9k

Countries citing papers authored by Michael H. Kroll

Since Specialization
Citations

This map shows the geographic impact of Michael H. Kroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Kroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Kroll more than expected).

Fields of papers citing papers by Michael H. Kroll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Kroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Kroll. The network helps show where Michael H. Kroll may publish in the future.

Co-authorship network of co-authors of Michael H. Kroll

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Kroll. A scholar is included among the top collaborators of Michael H. Kroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Kroll. Michael H. Kroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuban, J., Milan Patel, Peiman Habibollahi, et al.. (2024). Mechanical Venous Thrombectomy for Deep Venous Thrombosis in Cancer Patients: A Single-Center Retrospective Study. CardioVascular and Interventional Radiology. 47(5). 556–566.
2.
Kroll, Michael H., et al.. (2023). Thrombosis in hereditary hemorrhagic telangiectasia. Journal of Thrombosis and Haemostasis. 21(1). 18–20. 1 indexed citations
3.
Kroll, Michael H.. (2023). Checkpoint inhibitors. Hematology. 2023(1). 209–215. 2 indexed citations
4.
Li, Ang, Clark R. Andersen, Nathanael R. Fillmore, et al.. (2023). External validation of a novel electronic risk score for cancer‐associated thrombosis in a comprehensive cancer center. American Journal of Hematology. 98(7). 1052–1057. 9 indexed citations
5.
Hill, Ashley E., Ahmed Elakkad, J. Kuban, et al.. (2020). Durability of partial splenic artery embolization on platelet counts for cancer patients with hypersplenism-related thrombocytopenia. Abdominal Radiology. 45(9). 2886–2894. 7 indexed citations
6.
Agha, Ali, Dinu Valentin Balanescu, Teodora Donisan, et al.. (2020). Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography. Frontiers in Cardiovascular Medicine. 7. 9–9. 9 indexed citations
7.
Chamoun, Kamal, Sanam Loghavi, Naveen Pemmaraju, et al.. (2018). Early detection of transformation to BPDCN in a patient with MDS. Experimental Hematology and Oncology. 7(1). 26–26. 13 indexed citations
8.
9.
Ma, Qing, Roza Nurieva, Rebecca Patenia, et al.. (2012). Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation. Biology of Blood and Marrow Transplantation. 18(8). 1174–1181. 25 indexed citations
10.
Kroll, Michael H., et al.. (2011). Role of Factor Xa Inhibitors in Cancer-Associated Thrombosis: Any New Data?. Advances in Hematology. 2011. 1–12. 9 indexed citations
11.
Kroll, Michael H. & Shuju Feng. (2005). Targeting shear stress-induced platelet activation: is lesion-specific antiplatelet therapy a realistic clinical goal?. Expert Review of Cardiovascular Therapy. 3(5). 941–951. 14 indexed citations
12.
Reséndiz, Julio C., et al.. (2004). von Willebrand factor binding to platelet glycoprotein Ib‐IX‐V stimulates the assembly of an α‐actinin‐based signaling complex. Journal of Thrombosis and Haemostasis. 2(1). 161–169. 14 indexed citations
13.
Vilchez, Regis A., Claudia A. Kozinetz, Jeffrey L. Jorgensen, Michael H. Kroll, & Janet S. Butel. (2002). AIDS-Related Systemic Non-Hodgkin's Lymphoma at a Large Community Program. AIDS Research and Human Retroviruses. 18(4). 237–242. 17 indexed citations
14.
Christodoulides, Nicolaos, Shuju Feng, Julio C. Reséndiz, Michael C. Berndt, & Michael H. Kroll. (2001). Glycoprotein Ib/IX/V Binding to the Membrane Skeleton Maintains Shear-Induced Platelet Aggregation. Thrombosis Research. 102(2). 133–142. 18 indexed citations
15.
Stüben, Georg, Martin Stuschke, Michael H. Kroll, W. Havers, & Horst Sack. (1997). Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors. Radiotherapy and Oncology. 45(1). 3–10. 57 indexed citations
16.
Durante, William, Michael H. Kroll, Gregory Orloff, et al.. (1996). Regulation of interleukin-1β-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins. Biochemical Pharmacology. 51(6). 847–853. 13 indexed citations
17.
Rozenberg, Serge, Michael H. Kroll, Jean Vandromme, Marianne Paesmans, & H. R. Ham. (1996). Effect of bone density evaluation on hormone replacement therapy prescription. Maturitas. 24(1-2). 57–61. 4 indexed citations
18.
Durante, William, et al.. (1993). Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation. Platelets. 4(3). 135–140. 3 indexed citations
19.
Kroll, Michael H., T. Harris, Joel L. Moake, RI Handin, & A I Schafer. (1991). von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.. Journal of Clinical Investigation. 88(5). 1568–1573. 227 indexed citations
20.
Folts, John D., Bradford S. Schwartz, Michael H. Kroll, & A I Schafer. (1991). Streptokinase Inhibits Acute Platelet Thrombus Formation in Stenosed Dog Coronary Arteries. Platelets. 2(3). 145–152. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junji Nishioka Breakdown of academic impact, for papers by Claudia Maria Radu Breakdown of academic impact, for papers by Clifford M. Takemoto Breakdown of academic impact, for papers by Mercè Roqué Breakdown of academic impact, for papers by Kellie R. Machlus Breakdown of academic impact, for papers by Dolors Tàssies Breakdown of academic impact, for papers by Hatem H. Salem Breakdown of academic impact, for papers by Valerie P. Castle Breakdown of academic impact, for papers by Jaroslav Čermák Breakdown of academic impact, for papers by Norma Maugeri
Rankless by CCL
2026